Understanding Cardiac Long COVID

Understanding Cardiac Long COVID

Up next

What's Next for Lp(a)?

JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Lp(a)-Reducing Agent Pelacarsen Misses the Mark in Phase 3—Now What?" Related Content: Lp(a)-Reducing Agent Pelacarsen Misses the Mark in Phase 3—Now What? 

The Black Market for Investigational GLP-1 Drugs

JAMA Medical News Associate Managing Editor Kate Schweitzer and Lead Senior Staff Writer Rita Rubin discuss "Unapproved GLP-1 Drugs Retatrutide and Zenagamtide Sold Online Are No Bargain." Related Content: Unapproved GLP-1 Drugs Retatrutide and Zenagamtide Sold Online Are No Barg ...  Show more

Recommended Episodes

Covid-19 update: Cardiovascular disease, testing, social distancing and shielding, and dexamethasone
BMJ Best Practice Podcast

Kieran Walsh, clinical director at BMJ, asks editors from BMJ Learning and BMJ Best Practice to summarise the latest clinical guidance related to covid-19. Emma Scott discusses the latest guidance on cardiovascular disease. And Matt Castleden updates us on NHS Test and Trace, shi ...  Show more

Covid-19 update: Vaccination, long covid-19, endocrine conditions, bronchiolitis
BMJ Best Practice Podcast

Kieran Walsh, clinical director at BMJ, asks editors from BMJ Learning and BMJ Best Practice to summarise the latest clinical guidance related to covid-19. Matt Castleden, GP and section editor, updates us on vaccination and long covid-19. And Abigail Davis, GP and section editor ...  Show more

Covid-19 update: Management, vaccination and chronic conditions
BMJ Best Practice Podcast

Kieran Walsh, clinical director at BMJ, asks editors from BMJ Learning and BMJ Best Practice to summarise the latest clinical guidance related to covid-19. Matt Castleden, GP and section editor, updates us on pulse oximetry, prognostic scoring, and management in hospital. And Abi ...  Show more